ArriVent BioPharma, Inc. issues Regulation FD disclosure

ArriVent BioPharma, Inc. filed an 8-K covering a Regulation FD disclosure and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.